Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 1/20 | 0.47 |
| ▸ | CKS1B | P61024 | 9/20 | 0.44 |
| ▸ | SKP1 | P63208 | 9/20 | 0.44 |
| ▸ | SKP2 | Q13309 | 9/20 | 0.44 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.41 |
| ▸ | HTR7 | P34969 | 3/20 | 0.41 |
| ▸ | HTR1A | P08908 | 2/20 | 0.41 |
| ▸ | DRD2 | P14416 | 2/20 | 0.41 |
| ▸ | HTR6 | P50406 | 2/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.40 |
| ▸ | LDHA | P00338 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3269145 | 0.92 | P2RX7 (0.46) | P2RX7CKS1BSKP1SKP2HTR7 | |
| SCHEMBL3265672 | 0.90 | CHRM4 (0.45) | P2RX7LRRK2HTR7HTR1ADRD2 | |
| SCHEMBL3269143 | 0.86 | CKS1B (0.42) | P2RX7CKS1BSKP1SKP2HTR7 | |
| SCHEMBL3270076 | 0.85 | MALT1 (0.42) | P2RX7CKS1BSKP1SKP2LDHA | |
| SCHEMBL3267012 | 0.84 | KDM4E (0.59) | DRD2LDHAKDM4ERECQL | |
| SCHEMBL1727773 | 0.84 | P2RX7 (0.54) | P2RX7CKS1BSKP1SKP2LRRK2 | |
| SCHEMBL3269154 | 0.82 | HTR1A (0.43) | P2RX7HTR7HTR1ADRD2HTR6 | |
| SCHEMBL3269965 | 0.80 | DKK1 (0.57) | CKS1BSKP1SKP2 | |
| SCHEMBL3265642 | 0.79 | CKS1B (0.51) | CKS1BSKP1SKP2FAAHBCHE | |
| SCHEMBL3268917 | 0.78 | CKS1B (0.47) | CKS1BSKP1SKP2RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120004207-A1 | THERAPEUTIC USES OF DERIVATIVES OF PIPERIDINYL-AND PIPERIDINYL-ALKYL CARBAMATES | SANOFI-AVENTIS (FR) | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120004207-A1 | THERAPEUTIC USES OF DERIVATIVES OF PIPERIDINYL-AND PIPERIDINYL-ALKYL CARBAMATES | CLCN2, CLIC1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | P2RX7 1286/4885CKS1B 1534/4885SKP1 4286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.